Lifecore Biomedical, Inc. – NASDAQ:LFCR

Lifecore Biomedical stock price today

$7.25
-0.03
-0.41%
Financial Health
0
1
2
3
4
5
6
7
8
9

Lifecore Biomedical stock price monthly change

+44.73%
month

Lifecore Biomedical stock price quarterly change

+44.73%
quarter

Lifecore Biomedical stock price yearly change

+16.11%
year

Lifecore Biomedical key metrics

Market Cap
262.20M
Enterprise value
265.86M
P/E
-1.65
EV/Sales
0.97
EV/EBITDA
-3.77
Price/Sales
0.41
Price/Book
1.16
PEG ratio
N/A
EPS
-3.39
Revenue
159.84M
EBITDA
-3.30M
Income
-100.91M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-36.56%
Oper. margin
-6.66%
Gross margin
16.1%
EBIT margin
-6.66%
EBITDA margin
-2.07%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Lifecore Biomedical stock price history

Lifecore Biomedical stock forecast

Lifecore Biomedical financial statements

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Profit margin
Feb 2022 53.07M -12.85M -24.21%
May 2022 47.62M -36.47M -76.58%
Feb 2023 27.6M -15.46M -56.02%
May 2023 31.54M -36.13M -114.53%
Lifecore Biomedical, Inc. (NASDAQ:LFCR): Analyst Estimates
Aug 2025 32.77M -5.76M -17.58%
Nov 2025 39.45M 606.44K 1.54%
Feb 2026 42.16M 2.42M 5.75%
May 2026 46.92M 5.45M 11.63%
  • Analysts Price target

  • Financials & Ratios estimates

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Earnings per share (EPS)
2024-05-24 -0.23 0.427
2024-08-09 -0.12 -0.41
2024-08-26 -0.12 -0.15
Lifecore Biomedical, Inc. (NASDAQ:LFCR): Debt to assets
Aug 2022 285800000 188.90M 66.1%
Nov 2022 279073000 204.90M 73.42%
Feb 2023 236153000 201.94M 85.51%
May 2023 255150000 256.99M 100.72%
Lifecore Biomedical, Inc. (NASDAQ:LFCR): Cash Flow
Feb 2022 -20.12M 67.98M -47.09M
May 2022 35.99K -19.38M 19.14M
Feb 2023 -12.68M 6.39M 6.08M
May 2023 -17.28M -7.5M 20.90M

Lifecore Biomedical alternative data

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Employee count
Sep 2023 689
Oct 2023 689
Nov 2023 689
Dec 2023 689
Jan 2024 689
Feb 2024 689
Mar 2024 459
Apr 2024 459
May 2024 459
Jun 2024 459
Jul 2024 459

Lifecore Biomedical other data

22.35% -60.96%
of LFCR is owned by hedge funds
6.62M -18.06M
shares is hold by hedge funds

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Insider trades (number of shares)
Period Buy Sel
Oct 2024 1756097 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
LAKE RYAN DAVID officer: Chief Fi.. Common Stock 75,000 N/A N/A
Purchase
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner
Common Stock, $0.001 par value per share 169,753 $4.1 $695,987
Purchase
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner
Common Stock, $0.001 par value per share 122,930 $4.1 $504,013
Purchase
KIPER CHRISTOPHER S director, 10 percent owner:
Common Stock 1,311,312 $4.1 $5,376,379
Purchase
KIPER CHRISTOPHER S director, 10 percent owner:
Common Stock 152,102 $4.1 $623,618
Option
CALLOWAY NATHANIEL director
Common Stock 3,981 N/A N/A
Option
CALLOWAY NATHANIEL director
Restricted Stock Unit 3,981 N/A N/A
Option
OBUS NELSON director
Common Stock 9,554 N/A N/A
Option
OBUS NELSON director
Restricted Stock Unit 9,554 N/A N/A
Option
EDWARDS JEFFREY L director
Common Stock 9,554 N/A N/A
Sunday, 29 December 2024
accesswire.com
Tuesday, 24 December 2024
accesswire.com
Sunday, 22 December 2024
accesswire.com
Thursday, 19 December 2024
globenewswire.com
globenewswire.com
Wednesday, 18 December 2024
accesswire.com
Sunday, 15 December 2024
accesswire.com
Wednesday, 11 December 2024
accesswire.com
Sunday, 1 December 2024
seekingalpha.com
Tuesday, 26 November 2024
globenewswire.com
Thursday, 21 November 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Friday, 11 October 2024
globenewswire.com
Friday, 4 October 2024
seekingalpha.com
globenewswire.com
globenewswire.com
Thursday, 3 October 2024
globenewswire.com
Tuesday, 1 October 2024
globenewswire.com
Saturday, 28 September 2024
accesswire.com
Friday, 27 September 2024
globenewswire.com
accesswire.com
accesswire.com
accesswire.com
accesswire.com
Thursday, 26 September 2024
globenewswire.com
businesswire.com
accesswire.com
accesswire.com
  • What's the price of Lifecore Biomedical stock today?

    One share of Lifecore Biomedical stock can currently be purchased for approximately $7.25.

  • When is Lifecore Biomedical's next earnings date?

    Lifecore Biomedical, Inc. is estimated to report earnings on Friday, 8 Aug 2025.

  • Does Lifecore Biomedical pay dividends?

    No, Lifecore Biomedical does not pay dividends.

  • How much money does Lifecore Biomedical make?

    Lifecore Biomedical has a market capitalization of 262.20M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.2% to 128.26M US dollars. Lifecore Biomedical earned 12.01M US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.

  • What is Lifecore Biomedical's stock symbol?

    Lifecore Biomedical, Inc. is traded on the NASDAQ under the ticker symbol "LFCR".

  • What is Lifecore Biomedical's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Lifecore Biomedical?

    Shares of Lifecore Biomedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Lifecore Biomedical have?

    As Jul 2024, Lifecore Biomedical employs 459 workers.

  • When Lifecore Biomedical went public?

    Lifecore Biomedical, Inc. is publicly traded company for more then 29 years since IPO on 15 Feb 1996.

  • What is Lifecore Biomedical's official website?

    The official website for Lifecore Biomedical is lifecore.com.

  • Where are Lifecore Biomedical's headquarters?

    Lifecore Biomedical is headquartered at 3515 Lyman Boulevard, Chaska, MN.

  • How can i contact Lifecore Biomedical?

    Lifecore Biomedical's mailing address is 3515 Lyman Boulevard, Chaska, MN and company can be reached via phone at +95 2 368 4300.

Lifecore Biomedical company profile:

Lifecore Biomedical, Inc.

lifecore.com
Exchange:

NASDAQ

Full time employees:

524

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

3515 Lyman Boulevard
Chaska, MN 55318

CIK: 0001005286
ISIN: US5147661046
: